Royalty Pharma plc's latest marketcap:
As of 07/20/2026, Royalty Pharma plc's market capitalization has reached $33.84 B. According to our data, Royalty Pharma plc is the 765th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 33.84 B |
| Revenue (ttm) | 2.44 B |
| Net Income (ttm) | 826.29 M |
| Shares Out | 575.83 M |
| EPS (ttm) | 1.9 |
| Forward PE | 11.32 |
| Ex-Dividend Date | 05/15/2026 |
| Earnings Date | 08/05/2026 |
Royalty Pharma plc's yearly market capitalization.
| Date | Market Cap($) | Change (%) | Global Rank |
|---|---|---|---|
| 07/20/2026 | $33.84 B | 40.11% | 765 |
| 12/31/2025 | $22.3 B | 48.4% | 1315 |
| 12/31/2024 | $15.03 B | -10.44% | 1537 |
| 12/29/2023 | $16.78 B | -30.07% | 1342 |
| 12/30/2022 | $24 B | -0.82% | 943 |
| 12/31/2021 | $24.2 B | -20.37% | 1155 |
| 12/31/2020 | $30.39 B | 900 |
Company Profile
About Royalty Pharma plc
Royalty Pharma plc is a leading buyer of biopharmaceutical royalties and a key funder of innovation in the biopharmaceutical sector, primarily operating in the United States.
Portfolio Overview
The company's diverse portfolio includes royalties from:
- Approximately 35 marketed therapies
- 14 development-stage product candidates
These therapies and candidates span multiple therapeutic areas, including:
- Rare disease
- Cancer
- Neuroscience
- Infectious disease
- Hematology
- Diabetes
Company Background
Founded in 1996, Royalty Pharma is headquartered in New York, New York.
Frequently Asked Questions
-
What is Royalty Pharma plc's (RPRX) current market cap?As of 07/20/2026, Royalty Pharma plc (including the parent company, if applicable) has an estimated market capitalization of $33.84 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Royalty Pharma plc (RPRX) rank globally by market cap?Royalty Pharma plc global market capitalization ranking is approximately 765 as of 07/20/2026. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.